Purchase Order 75N95019P00342
Award Date 6/11/19
Potential Completion Date 6/10/23
Potential Value $728K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
Total Small Business
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30309, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $130,289 firm fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency under the Department of Health and Human Services, to Axion Biosystems, Inc., a foreign-owned, for-profit manufacturer of specialized laboratory equipment and instruments. The contract is for the delivery of Axion's proprietary Maestro multi-electrode array (MEA) systems, Maestro Apex automated incubators, and related accessories like optical stimulation modules...
- The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $203,800.00 firm fixed-price purchase order to Axion Biosystems, Inc., a foreign-owned for-profit manufacturer, for the Maestro Pro microelectrode array (MEA) system and related support services. This non-competitive acquisition was conducted under FAR Simplified Acquisition Procedures for commercial items to support the Stem Cell Translation Laboratory (SCTL) within the...
- This federal contract award, valued at $24,440.00, was issued by the National Center for Advancing Translational Sciences (NCATS) within the National Institutes of Health (NIH) to Axion Biosystems, Inc., a foreign-owned, for-profit manufacturer of specialized laboratory equipment. The contract is for the delivery of 10 boxes of 48-well Axion CytoView microelectrode array (MEA) plates, which are required for neurotoxicity screening assays as part of the HEAL siRNA/ASO toxicity collaborative...
- This is a $110,200.00 firm fixed price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), which is a civilian agency within the U.S. Department of Health and Human Services. The contract is for a service and maintenance agreement for an Axion Biosystems instrument, which is likely one of the company's proprietary Maestro multi-electrode array (MEA) systems or related cell analysis platforms. Axion Biosystems, Inc. is the prime contractor, and the contract...
- This is a firm-fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency under the Department of Health and Human Services (HHS). The contract, valued at $12,960.00, is for the delivery of CYTOVIEW MEA 48-WELL WHITE PLATE (BOX OF 5) by the prime contractor, Axion Biosystems, Inc., a foreign-owned for-profit manufacturer of laboratory equipment and instruments. The contract does not have a set-aside designation and has an ultimate...
- This is a $152,766 firm fixed price purchase order awarded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), a civilian federal agency, to the small business Axion Biosystems, Inc. The contract is for Axion's MaestroPro 768-channel multi-electrode array (MEA) system, neural applications software, related MEA plates, installation and training. This specialized equipment is needed to investigate how neural circuit activity changes in response to temperature variations, in order to...
- This is a firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to Axion Biosystems, Inc., a foreign-owned, for-profit manufacturer of specialized laboratory equipment. The $149,750.00 contract is for the delivery of Lumos multiwell consumable plates to be used with Axion's proprietary Maestro multi-electrode array (MEA) system, which supports biomedical and drug development research...
- The National Institutes of Health National Institute on Drug Abuse awarded a $535,550 firm fixed price purchase order to Axion Biosystems, Inc. for the acquisition of a Maestro APEX automated incubator system and a Maestro MEA 768-channel multi-well system. The systems will support NIDA's therapeutic development programs, as solicited in the combined synopsis and solicitation seeking offers for the goods and services. Axion Biosystems will provide the Maestro systems, four days of installation...
- This is a $72,000 firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to Axion Biosystems, Inc., a foreign-owned manufacturer, for the procurement of 16 boxes of 48-well and 16 boxes of 96-well Axion CytoView microelectrode array plates. The purchase order supports NCATS' Division of Preclinical Innovation's Therapeutic Development Branch and their N=1 antisense oligonucleotide (ASO)...
- This federal contract award, valued at $149,845.00, was issued by the National Institute on Drug Abuse (NIDA), a civilian agency under the Department of Health and Human Services (HHS). The contract was awarded to Axion Biosystems, Inc., a foreign-owned, for-profit manufacturer of specialized live cell analysis technologies, primarily its Maestro multi-electrode array (MEA) systems and related instrumentation and consumables. The contract does not have a set-aside designation. Axion Biosystems...